8-KRegulation FDExhibits & Filings

DEXCOM INC 8-K Report, Regulation FD Disclosure (Jun 26, 2023)

Filed June 26, 2023For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on June 26, 2023, primarily to disclose information presented at their Investor Day on June 23, 2023. The key takeaway for investors is an update to the company's long-range financial targets. While the specific updated targets are detailed in the furnished press release (Exhibit 99.1), this filing indicates a forward-looking strategic communication from DexCom regarding its growth trajectory and financial outlook. Investors should review the associated press release and Investor Day presentation, which are referenced in the filing and available on DexCom's investor relations website, for comprehensive details on these updated financial goals. This information is crucial for understanding management's expectations for future performance and assessing the company's long-term value proposition. It's important to note that the information furnished under Item 7.01 is not considered "filed" and therefore does not carry the same regulatory implications as formally filed information.

Key Highlights

  • 1DexCom announced updates to its long-range financial targets during its Investor Day on June 23, 2023.
  • 2The filing includes a press release dated June 23, 2023, as Exhibit 99.1, containing these financial target updates.
  • 3The company also made the press release and Investor Day presentation available on its investor relations website.
  • 4This 8-K filing is primarily for Regulation FD disclosure, sharing material information with the public.
  • 5The information furnished under Item 7.01 is not deemed 'filed' for the purposes of Section 18 of the Exchange Act.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose updates to DexCom's long-range financial targets and other information shared during their Investor Day event. It serves as a Regulation FD disclosure to ensure all investors receive this material information simultaneously.

The detailed updated long-range financial targets are provided in the press release dated June 23, 2023, which is furnished as Exhibit 99.1 to this 8-K filing. Additionally, the press release and the full Investor Day presentation are available on DexCom's investor relations website at investors.dexcom.com.

No, this 8-K filing does not contain updated financial statements. It is a disclosure of forward-looking financial targets and strategic information presented at an Investor Day event. The information is furnished, not filed, and is not incorporated by reference into other SEC filings unless expressly stated.